RESMED INC

RMD 10-Q · Q2 2026
API behind this page

RMD Q2 2026 request

Playground key active
Request URL /api/financials?ticker=RMD&year=2026&quarter=2
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q2 2026 Q2 2025 YoY
Revenue 1,422,808 1,282,089 +11.0%
Show Product Lines breakouts
Devices · Combined Europe, Asia and other markets 278,167 254,849 +9.1%
Devices · Global revenue 726,214 669,302 +8.5%
Devices · U.S., Canada and Latin America 448,047 414,453 +8.1%
Masks and other · Combined Europe, Asia and other markets 142,740 121,795 +17.2%
Masks and other · Global revenue 529,724 456,291 +16.1%
Masks and other · U.S., Canada and Latin America 386,984 334,496 +15.7%
Residential Care Software 166,870 156,496 +6.6%
Residential Care Software · Global revenue 166,870 156,496 +6.6%
Sleep And Breathing Health [Member] 1,255,938 1,125,593 +11.6%
Sleep And Breathing Health [Member] · Global revenue 1,255,938 1,125,593 +11.6%
Show Business Segments breakouts
Residential Care Software 166,870 156,496 +6.6%
Sleep And Breathing Health [Member] 1,255,938 1,125,593 +11.6%
Show Geography breakouts
Combined Europe, Asia and other markets 420,907 376,644 +11.8%
Global revenue 1,422,808 1,282,089 +11.0%
U.S., Canada and Latin America 835,031 748,949 +11.5%
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization 536,276 523,180 +2.5%
Show Product Lines breakouts
Residential Care Software 51,484 49,792 +3.4%
Sleep And Breathing Health [Member] 484,792 473,388 +2.4%
Amortization Of Intangible Assets 7,808 7,634 +2.3%
Show Product Lines breakouts
Residential Care Software 6,393 6,404 -0.2%
Sleep And Breathing Health [Member] 1,415 1,230 +15.0%
Cost of Revenue 544,084 530,814 +2.5%
Show Business Segments breakouts
Residential Care Software · Operating Segments 51,484 49,792 +3.4%
Sleep And Breathing Health [Member] · Operating Segments 482,252 467,970 +3.1%
Show Consolidation Items breakouts
Operating Segments 533,736 517,762 +3.1%
Gross Profit 878,724 751,275 +17.0%
Selling, General & Administrative 278,396 241,613 +15.2%
Show Business Segments breakouts
Residential Care Software · Operating Segments 39,550 33,736 +17.2%
Sleep And Breathing Health [Member] · Operating Segments 147,740 118,831 +24.3%
Show Consolidation Items breakouts
Operating Segments 187,290 152,567 +22.8%
Research & Development 90,969 81,372 +11.8%
Show Business Segments breakouts
Residential Care Software · Operating Segments 25,789 24,085 +7.1%
Sleep And Breathing Health [Member] · Operating Segments 54,096 50,071 +8.0%
Show Consolidation Items breakouts
Operating Segments 79,885 74,156 +7.7%
Amortization Of Acquired Intangible Assets1 11,764 11,047 +6.5%
Show Consolidation Items breakouts
Material Reconciling Items 19,572 18,681 +4.8%
Restructuring Charges 5,935 — —
Show Consolidation Items breakouts
Material Reconciling Items 5,935 — —
Operating Expenses 387,064 334,032 +15.9%
Operating Income 491,660 417,243 +17.8%
Show Business Segments breakouts
Residential Care Software · Operating Segments 50,047 48,882 +2.4%
Sleep And Breathing Health [Member] · Operating Segments 571,850 488,721 +17.0%
Show Consolidation Items breakouts
Operating Segments 621,897 537,603 +15.7%
Interest Income Expense Nonoperating Net 7,949 -775 +1125.7%
Show Consolidation Items breakouts
Material Reconciling Items -7,949 775 -1125.7%
Income Loss From Equity Method Investments 1,515 1,077 +40.7%
Show Consolidation Items breakouts
Material Reconciling Items 1,515 1,077 +40.7%
Equity Securities Fv Ni Gain Loss 306 -1,439 +121.3%
Other Non-Operating Income (Expense) -5,282 2,216 -338.4%
Show Consolidation Items breakouts
Material Reconciling Items 5,282 -2,216 +338.4%
Non-Operating Income (Expense) 4,488 1,079 +315.9%
Income Before Taxes 496,148 418,322 +18.6%
Show Consolidation Items breakouts
Material Reconciling Items 496,148 418,322 +18.6%
Income Tax Expense (Benefit) 103,555 73,700 +40.5%
Net Income 392,593 344,622 +13.9%
Show Equity Components breakouts
Retained Earnings 392,593 344,622 +13.9%
EPS (Basic) 2.69 2.35 +14.5%
EPS (Diluted) 2.68 2.34 +14.5%
Common Stock Dividends Per Share Declared 0.6 0.53 +13.2%
Wtd Avg Shares (Basic) 145,842 146,810 -0.7%
Wtd Avg Shares (Diluted) 146,372 147,481 -0.8%
Comprehensive Income 423,446 177,887 +138.0%
Operating Lease Lease Income 25.3 24.1 +5.0%

Balance Sheet

Balance Sheet
Metric Q2 2026 Q2 2025 YoY
Current Assets
Cash & Cash Equivalents 1,417,069 — —
Show Cash And Cash Equivalents breakouts
High Yield Cash And Cash Equivalent 460.9 — —
Accounts Receivable 985,634 859,937 +14.6%
Show Balance Sheet Location breakouts
Accounts receivable, net 985,634 859,937 +14.6%
Inventory 922,045 882,103 +4.5%
Prepaid Expenses & Other Current Assets 494,053 572,193 -13.7%
Total Current Assets 3,818,801 2,836,177 +34.6%
Non-Current Assets
Property, Plant & Equipment 564,254 520,162 +8.5%
Operating Lease Right-of-Use Assets 165,916 151,012 +9.9%
Goodwill 3,044,370 2,805,353 +8.5%
Show Business Segments breakouts
Residential Care Software 2,160,425 2,058,330 +5.0%
Sleep And Breathing Health [Member] 883,945 747,023 +18.3%
Intangible Assets 430,240 438,003 -1.8%
Show Finite Lived Intangible Assets By Major Class breakouts
Customer Relationships 269,556 259,042 +4.1%
Developed/core product technology 65,390 87,249 -25.1%
Other Intangible Assets 95,294 91,712 +3.9%
Deferred Income Taxes And Other Assets Noncurrent 285,907 209,445 +36.5%
Other Non-Current Assets 193,882 181,182 +7.0%
Assets Noncurrent 4,684,569 4,305,157 +8.8%
Total Assets 8,503,370 7,141,334 +19.1%
Current Liabilities
Accounts Payable 250,406 220,313 +13.7%
Accrued Liabilities 391,500 352,541 +11.1%
Operating Lease Liability Current 29,759 27,812 +7.0%
Deferred Revenue (Current) 176,050 156,508 +12.5%
Show Balance Sheet Location breakouts
Deferred revenue (current liabilities) 176,050 156,508 +12.5%
Accrued Income Taxes Current 140,493 84,880 +65.5%
Short Term Borrowings 259,906 9,906 +2523.7%
Total Current Liabilities 1,248,114 851,960 +46.5%
Non-Current Liabilities
Contract With Customer Liability Noncurrent 159,789 146,512 +9.1%
Show Balance Sheet Location breakouts
Deferred revenue (non-current liabilities) 159,789 146,512 +9.1%
Deferred Income Taxes And Other Tax Liabilities Noncurrent 77,994 77,004 +1.3%
Operating Lease Liabilities 154,133 139,159 +10.8%
Other Non-Current Liabilities 138,538 10,831 +1179.1%
Long-Term Debt 403,923 662,859 -39.1%
Liabilities Noncurrent 934,377 1,036,365 -9.8%
Total Liabilities 2,182,491 1,888,325 +15.6%
Stockholders' Equity
Common Stock Value Outstanding 763 760 +0.4%
Additional Paid In Capital Common Stock 2,102,992 1,957,359 +7.4%
Retained Earnings 6,647,285 5,492,038 +21.0%
Treasury Stock Common Value -2,400,298 -1,898,258 -26.4%
Accumulated Other Comprehensive Income -29,863 -298,890 +90.0%
Total Stockholders' Equity 6,320,879 5,253,009 +20.3%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -29,863 -298,890 +90.0%
Additional Paid In Capital 2,102,992 1,957,359 +7.4%
Common Stock 763 760 +0.4%
Retained Earnings 6,647,285 5,492,038 +21.0%
Treasury Stock Common -2,400,298 -1,898,258 -26.4%
Total Liabilities & Equity 8,503,370 7,141,334 +19.1%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q2 2026 YTD Q2 2025 YoY
Operating Activities
Depreciation & Amortization 97,583 91,169 +7.0%
Show Business Segments breakouts
Residential Care Software · Operating Segments 5,350 4,608 +16.1%
Sleep And Breathing Health [Member] · Operating Segments 52,345 48,268 +8.4%
Show Consolidation Items breakouts
Corporate Non Segment 39,888 38,293 +4.2%
Operating Lease Right Of Use Asset Amortization Expense 22,416 18,443 +21.5%
Stock-Based Compensation 50,098 42,790 +17.1%
Debt And Equity Securities Unrealized Gain Loss 5,884 2,119 +177.7%
Show Consolidation Items breakouts
Material Reconciling Items 5,884 2,119 +177.7%
Change in Accounts Receivable -42,712 -31,436 -35.9%
Change in Inventory 11,466 -77,895 +114.7%
Change in Prepaid & Other Assets -104,075 -43,746 -137.9%
Increase Decrease In Accounts Payable And Accrued Liabilities 18,281 -21,220 +186.1%
Net Cash from Operations 797,066 634,161 +25.7%
Investing Activities
Capital Expenditures -71,504 -38,484 -85.8%
Payment For Patent Registration And Acquisition Costs -7,351 -4,592 -60.1%
Payments To Acquire Intangible Assets -1,479 -4,592 +67.8%
Payments To Acquire Businesses Net Of Cash Acquired -522 -670 +22.1%
Payments To Acquire Investments -6,404 -2,350 -172.5%
Proceeds From Sale Maturity And Collections Of Investments 250 4,378 -94.3%
Payments For Proceeds From Derivative Instrument Investing Activities -16,510 7,172 -330.2%
Net Cash from Investing -103,520 -34,546 -199.7%
Financing Activities
Proceeds From Issuance Of Common Stock 37,762 35,260 +7.1%
Tax Withholding for Share Compensation -21,027 -17,123 -22.8%
Share Repurchases -325,024 -124,991 -160.0%
Repayments Of Long Term Debt -5,000 -35,000 +85.7%
Payments Of Dividends -175,334 -155,586 -12.7%
Net Cash from Financing -488,623 -298,295 -63.8%
Supplemental
Income Taxes Paid 209,419 224,351 -6.7%
Interest Paid 13,466 7,285 +84.8%
Noncash Part Of Acquisition Fair Value Of Assets Acquired -798 — —
Goodwill Acquired During Period Increase Decrease 1,320 — —
Payments To Acquire Businesses Gross 522 1,525 -65.8%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2,696 -17,737 +115.2%
Net Change in Cash 207,619 283,583 -26.8%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,417,069 521,944 +171.5%

Values in thousands USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key